Preview

Medical Parasitology and Parasitic Diseases

Advanced search
Open Access Open Access  Restricted Access Subscription or Fee Access

Strategy of selection for species and strains of the genus Pleurotus, producers of antiparasitic and antifungal metabolites

https://doi.org/10.33092/0025-8326mp2025.4.20-27

Abstract

Introduction. The search for new antiparasitic and antifungal agents is becoming increasingly relevant due to the widespread occurrence of helminthiasis and invasive mycoses, as well as the increasing resistance of pathogens. Mushrooms of the genus Pleurotus are considered as a promising source of biologically active metabolites.

The aim of the work was to evaluate the spectrum of antifungal activity of metabolites of eight strains of the genus Pleurotus grown in a submerged culture.

Materials and methods. Ethyl acetate extracts of culture liquid and ethanol extracts of mycelium were studied. Antifungal activity was assessed by the diffusion method in relation to ten clinically significant test objects, including pathogens from the priority list of the World Health Organization (Candida albicans, Candidozyma auris, Aspergillus fumigatus and others).

Results. Ethyl acetate extracts of the culture fluid exhibit higher and broader antifungal activity compared to mycelium extracts. The most active strains were Pleurotus ostreatus M-37 and Pleurotus citrinopileatus 1 against critically important pathogens C. albicans, C. auris and A. fumigatus.

Conclusion. The most promising producers of antifungal compounds among the studied strains were P. ostreatus M-37 and P. citrinopileatus 1. The revealed antifungal activity, combined with the known nematocidal properties of oyster mushrooms, allows them to be considered as a universal platform for the search for new remedies against mycoses and parasitoses.

About the Authors

A. V. Avtonomova
Federal State Budgetary Institution «Centre for Strategic Planning and Management of Biomedical Health Risks» of the Federal medical and biological agency»; Federal State Budgetary Scientific Institution «Gause Institute of New Antibiotics»
Russian Federation

Moscow



A. V. Zagainova
Federal State Budgetary Institution «Centre for Strategic Planning and Management of Biomedical Health Risks» of the Federal medical and biological agency»
Russian Federation

Moscow



I. V. Kurbatova
Federal State Budgetary Institution «Centre for Strategic Planning and Management of Biomedical Health Risks» of the Federal medical and biological agency»
Russian Federation

Moscow



A. F. Shegurova
Federal State Budgetary Institution «Centre for Strategic Planning and Management of Biomedical Health Risks» of the Federal medical and biological agency»
Russian Federation

Moscow



E. S. Kravchenko
Federal State Budgetary Institution «Centre for Strategic Planning and Management of Biomedical Health Risks» of the Federal medical and biological agency»
Russian Federation

Moscow



M. A. Antimonova
Federal State Budgetary Scientific Institution «Gause Institute of New Antibiotics»
Russian Federation

Moscow



L. M. Krasnopolskaya
Federal State Budgetary Scientific Institution «Gause Institute of New Antibiotics»
Russian Federation

Moscow



References

1. Framework for control and prevention of soil-transmitted helminthiases in the WHO European Region 2016–2020 // World Health Organization. 2016; 40 p.

2. On the state of sanitary and epidemiological welfare of the population in the Russian Federation in 2024: State Report. Moscow: Federal Service for Supervision of Consumer Rights Protection and Human Well-being. 2025; 424 p (in Russian).

3. Akimkin V.G., Tutelyan A.V., Shulakova N.I. Medical mycological iceberg: recent trends in the epidemiology of mycoses // Infektsionnye bolezni. 2022; 20(4): 120–126 (in Russian). DOI: 10.20953/1729-9225-2022-1-120-126.

4. Antifungal agents in clinical and preclinical development Overview and analysis. World Health Organization. 2025; 88 p.

5. Rodríguez-Barrera T.M., Téllez-Téllez M., Sánchez J.E., Castañeda-Ramirez G.S., Acosta-Urdapilleta M., Bautista-Garfias C.R., Aguilar-Marcelino L. Edible mushrooms of the genus Pleurotus as biocontrol agents of parasites of importance for livestock // Scientia fungorum. 2021; 52: 1-12 DOI: 10.33885/sf.2021.52.1375.

6. Giacometi M., Gressler L.T., Dos Santos Petry L., de Matos A.F.M., Dillmann J.B., Dos Santos T.S., Monteiro S.G. Antioxidant and nematocidal effects of several oyster mushroom species of genus Pleurotus (Agaricomycetes) //International Journal of Medicinal Mushrooms. 2022; 24(6): 35-45.

7. Elkhateeb W.A., Daba G. M., Soliman G. M. The anti-nemic potential of mushroom against plant-parasitic nematodes // Journal of Microbiology and Biotech. 2021; 6(1): 1-6.

8. Li G.H., Zhang K.Q. Nematode-toxic fungi and their nematicidal metabolites // Nematode-trapping fungi. 2014; 23: 313-375.

9. Azevedo M.L., Gonçalves C.L., Alves A.M., Wille C.N., Etges A., da Silva Nascente P.I., Lund R.G. Aqueous extracts of Lentinula edodes, Pleurotus pulmonarius, and Pleurotus sajor-caju: Antifungal activity and inhibition of exoenzyme production by Candida albicans // Journal of Medicinal Plants Research. 2022; 16(10): 300-305. DOI: 10.5897/JMPR2022.7252

10. Owaid M.N., Al-Saeedi S.S.S., Al-Assaffii I.A.A. Antifungal activity of cultivated oyster mushrooms on various agro-wastes // Summa Phytopathologica. 2017; 43(1): 9-13. DOI: 10.1590/0100-5405/2069.

11. Dawood S.M., Abdulrazzaq A.K., Shnawa K.T., Hanawi M.J. In Vitro Antifungal Activity of of Pleurotuseryngii against Trichophytonrubrum // Indian Journal of Forensic Medicine & Toxicology. 2021; 15(4): 2363-2370. DOI: 10.37506/ijfmt.v15i4.17059.

12. Dahima V., Doshi A., Singh H. Screening of Antifungal Activity of Pleurotus pulmonarius, Pleurotus florida and Shizophyllum commune // J. Curr. Microbiol. Appl. Sci. 2020; 9(4): 997-1004. DOI: 10.20546/ijcmas.2020.904.118.

13. Owaid M.N., Al-Saeedi S.S.S., Al-Assaffii I.A.A. Antimicrobial activity of mycelia of oyster mushroom species (Pleurotus spp.) and their liquid filtrates (in vitro) // Journal of Medical and Bioengineering. 2015; 4(5): 997-1004.

14. Younis A.M., Wu F.S., El Shikh H.H. Antimicrobial activity of extracts of the oyster culinary medicinal mushroom Pleurotus ostreatus (higher basidiomycetes) and identification of a new antimicrobial compound // International journal of medicinal mushrooms. 2015; 17(6): 579-590.

15. Krasnopol'skaya L.M., Belickij I.V., Fedorova G.B., Katruha G.S. Pleutotus djamor: cultivation methods and antimicrobial properties // Mycology and phytopathology. 2001; 35(1): 62-67. (in Russian)

16. WHO fungal priority pathogens list to guide research, development and public health action. World Health Organization. 2022; 48 p. URL: https://iris.who.int/bitstream/handle/10665/363682/9789240060241-eng.pdf?sequence=1 (дата обращения 18.10.2025).


Review

For citations:


Avtonomova A.V., Zagainova A.V., Kurbatova I.V., Shegurova A.F., Kravchenko E.S., Antimonova M.A., Krasnopolskaya L.M. Strategy of selection for species and strains of the genus Pleurotus, producers of antiparasitic and antifungal metabolites. Medical Parasitology and Parasitic Diseases. 2025;(4):20-27. (In Russ.) https://doi.org/10.33092/0025-8326mp2025.4.20-27

Views: 143

JATS XML

ISSN 0025-8326 (Print)
ISSN 2713-1777 (Online)